The data shows a consistent trend of average time to pay for SHIRE EUROPE LIMITED from 2018 to 2019. There is no significant change in the percentage of invoices paid within 30 days, between 31 and 60 days, or later than 60 days. Additionally, the percentage of invoices not paid within agreed terms remains the same for all three periods.
The data for SHIRE EUROPE LIMITED does not show any significant volatility in terms of average time to pay or percentage of invoices paid within different time frames. There is no major fluctuation in these values, indicating a stable payment pattern for the company.
From the data, it can be observed that SHIRE EUROPE LIMITED has maintained a consistent average time to pay for invoices over the course of three periods. The company also consistently pays the majority of its invoices within 30 days, with no significant changes in this percentage. However, there is room for improvement in terms of paying invoices within the agreed terms, as the percentage of invoices not paid within the agreed terms remains the same for all three periods.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 |
SHIRE EUROPE LIMITED is a leading biotechnology company based in the United Kingdom. The company is dedicated to providing innovative solutions to improve the lives of people with rare diseases and other specialized conditions.
The company has a strong focus on sustainability and is committed to reducing its environmental impact. This is reflected in their sustainability program, which includes initiatives such as waste reduction, energy efficiency, and responsible sourcing of materials.
SHIRE EUROPE LIMITED offers a wide range of products and services, including medicines, therapies, and genetic testing for rare diseases. They also provide support and resources to patients and their families through education and advocacy programs.
The company is led by a team of experienced and dedicated professionals, including CEO Flemming Ornskov and Chairman Matthew Emmens. They are supported by a diverse and talented workforce, who are passionate about making a positive impact in the healthcare industry.
For more information on SHIRE EUROPE LIMITED and their products and services, you can visit their website at www.shire.com. Their registered office address is 5 New Square, Bedfont Lakes, Feltham, Middlesex, TW14 8HA, United Kingdom.